Is there still a role for prostatic acid phosphatase? CSCC Position Statement. Canadian Society of Clinical Chemists (Q73363928)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10638940%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Is there still a role for prostatic acid phosphatase? CSCC Position Statement. Canadian Society of Clinical Chemists (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10638940%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

P S Bunting

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10638940%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 November 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10638940%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

published in

Clinical Biochemistry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10638940%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10638940%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10638940%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

591-594

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10638940%20AND%20SRC:MED&resulttype=core&format=json

A guide to the interpretation of serum prostate specific antigen levels

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900068-5

Clinical behavior of prostatic specific antigen and prostatic acid phosphatase: a comparative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900068-5

Relative value of prostate-specific antigen and prostatic acid phosphatase in diagnosis and management of adenocarcinoma of prostate. Ohio State University experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900068-5

Prostate Specific Antigen and Prostatic Acid Phosphatase for Monitoring Therapy of Carcinoma of the Prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900068-5

A comparative study on the diagnostic value of prostatic acid phosphatase (PAP) and prostatic specific antigen (PSA) in patients with carcinoma of the prostate gland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900068-5

Comparative clinical features of stage A1 and stage A2 prostate cancers. Is the concept of stage A changing from the current status?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900068-5

Prostate-specific antigen in mass screening for carcinoma of the prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900068-5

A reappraisal of serial isotope bone scans in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900068-5

Levels of prostate specific antigen that predict skeletal spread in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900068-5

Prediction of pelvic lymph node metastases by a prostate-specific antigen and prostatic acid phosphatase in clinical T3/T4M0 prostatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900068-5

Prostate-specific antigen as a unique routine test in monitoring therapy for inoperable prostate cancer: comparison with radionuclide bone scan and prostatic acid phosphatase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900068-5

Relationship between prostate-specific antigen, clinical stage, and degree of bone metastasis in patients with prostate cancer: comparison with prostatic acid phosphatase and alkaline phosphatase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900068-5

Prognostic factors in metastatic prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900068-5

Multicenter, randomized, double-blind, placebo controlled study to investigate the effect of finasteride (MK-906) on stage D prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900068-5

Comparison of prostate secretory protein with prostate specific antigen and prostatic acid phosphatase as a serum biomarker for diagnosis and monitoring patients with prostate carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900068-5

Tumor marker doubling time in patients with prostate cancer: determination of prostate-specific antigen and prostatic acid phosphatase doubling time

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900068-5

Prognostic factors in patients with prostate cancer refractory to endocrine therapy: univariate and multivariate analyses including doubling times of prostate-specific antigen and prostatic acid phosphatase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900068-5

Prognostic factors in prostate cancer. Analysis of 874 patients treated with radiation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900068-5

Acid phosphatase: defining a role in androgen-independent prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900068-5

Comparative analysis of fluctuation of serum tumor markers in advanced cancer of prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900068-5

Serial monitoring of patients with prostate cancer treated with anti-androgen therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900068-5

Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900068-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Prostate-specific antigen and prostatic acid phosphatase in the detection of early prostate cancer and in the prediction of regional lymph node metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900068-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0009-9120(99)00068-5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10638940%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference